Pain Therapeutics (PTIE) Lower as Durect (DRRX) Gets CRL from FDA for POSIDUR
Tweet Send to a Friend
Pain Therapeutics, Inc. (NASDAQ: PTIE) lower after Durect ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
